Efficacy of Carbetocin Versus Oxytocin Plus Misoprostol in Decreasing Blood Loss During Cesarean Section
Status:
Not yet recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial is to test if carbetocin is as effective as oxytocin plus
misoprostol in decreasing intraoperative blood loss in women undergoing planned cesarean
section.
The main question it aims to answer is:
* Is carbetocin as effective as oxytocin plus misoprostol in decreasing intraoperative blood
loss in women undergoing planned cesarean section?
Researchers will compare 2 groups:
- women receiving Oxytocin plus Misoprostol;
- women receiving Carbetocin as regards:
- estimated blood loss